BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20681961)

  • 1. Clinical audit of antiphospholipid antibody testing in tertiary practice: towards improved relevance in thrombophilia investigations.
    Favaloro EJ; Reben R; Mohammed S; Koutts J
    Intern Med J; 2012 Apr; 42(4):427-34. PubMed ID: 20681961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey.
    Favaloro EJ; Wong RC
    Pathology; 2009; 41(7):666-75. PubMed ID: 20001347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?
    Berkun Y; Simchen MJ; Strauss T; Menashcu S; Padeh S; Kenet G
    Lupus; 2014 Sep; 23(10):986-93. PubMed ID: 24729280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real world experience with antiphospholipid antibody tests: how stable are results over time?
    Erkan D; Derksen WJ; Kaplan V; Sammaritano L; Pierangeli SS; Roubey R; Lockshin MD
    Ann Rheum Dis; 2005 Sep; 64(9):1321-5. PubMed ID: 15731290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulants.
    Favaloro EJ
    Int J Lab Hematol; 2013 Jun; 35(3):269-74. PubMed ID: 23590654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLC immunostaining for detection of "antiphospholipid" antibodies.
    Conti F; Alessandri C; Spinelli FR; Capozzi A; Martinelli F; Recalchi S; Misasi R; Valesini G; Sorice M
    Methods Mol Biol; 2014; 1134():95-101. PubMed ID: 24497357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.
    Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP
    J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory examinations in antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2010 Apr; 58(4):343-51. PubMed ID: 20496762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA anticardiolipin antibodies--relation with other antiphospholipid antibodies and clinical significance.
    Selva-O'Callaghan A; Ordi-Ros J; Monegal-Ferran F; Martinez N; Cortes-Hernandez F; Vilardell-Tarres M
    Thromb Haemost; 1998 Feb; 79(2):282-5. PubMed ID: 9493576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation and recommended testing for antiphospholipid antibodies.
    Galli M
    Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the antiphospholipid syndrome in primary systemic vasculitis.
    Rees JD; Lança S; Marques PV; Gómez-Puerta JA; Moco R; Oliveri C; Khamashta MA; Hughes GR; D'Cruz DP
    Ann Rheum Dis; 2006 Jan; 65(1):109-11. PubMed ID: 16344494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical consequences of antiphospholipid antibodies.
    Derksen RH; de Groot PG
    Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.